Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety
| Title: | Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety |
|---|---|
| Authors: | Tang, Ansel Shao PinAff1; Hsu, Jovan Teng YuanAff1; Chong, Sheena Kar ShuanAff1; Quek, JingxuanAff1; Shek, GenevieveAff2; Sulaimi, FarisahAff2; Chan, Kai EnAff1; Anand, Vickram VijayAff3; Chong, BryanAff1; Mehta, AnuragAff4; Toh, Sue-AnneAff1, Aff5, Aff6, Aff7; Muthiah, MarkAff8, Aff9; Dimitriadis, Georgios K.Aff10, Aff11; le Roux, Carel W.Aff12, Aff13; Chan, Mark Yan-YeeAff1, Aff14; Mamas, Mamas AndreasAff15; Chin, Yip HanAff16; Chew, Nicholas W. S.Aff1, Aff14, IDs12933025028403_cor1 |
| Source: | Cardiovascular Diabetology. 24(1) |
| Database: | Springer Nature Journals |